Make sure you don’t land on Santa’s naughty list for overindulging in all of your favorite holiday foods. A Baylor College of Medicine family physician says staying active is the best way to counteract holiday calories.
SA study published in the journal Cell Stem Cell reveals a new mechanism that contributes to adult bone maintenance and repair and opens the possibility of developing therapeutic strategies for improving bone healing.
Researchers reported that profiling the bone marrow “metabolome" at the time of pediatric acute lymphoblastic leukemia diagnosis enabled them to identify patients who were most likely to respond poorly to treatment.
Regular exercise or sports participation is a great way to sustain a healthy lifestyle, but mistakes in your training could lead to injury. Dr. Theodore Shybut discusses common mistakes that can result in injury.
The Women’s World Cup is in the limelight and it’s an important reminder of the prevention of and recovery from ACL tears. A sports medicine expert discusses this injury and why female soccer players are at risk.
A potentially disease-modifying therapy for osteoarthritis has reached a key milestone now that a U.S. patent has been issued for FX201, a gene-therapy product candidate based on work led by Baylor researchers.
About 54 million Americans have low bone mass, putting them at risk of developing osteoporosis. During National Osteoporosis Awareness Month, Dr. Brendan Lee explains the causes and risk factors of osteoporosis.
This holiday season, planning ahead can help you establish a workout routine so you can enjoy your favorite holiday treats with less guilt. Dr. Theodore Shybut says to start now and offers safety tips to help avoid injury.
In sports it’s said that the best offense is a good defense, and that can be true for falls too – two orthopedic surgeons offer prevention tips and discuss common injuries that can occur when people fall.
Researchers at Baylor College of Medicine have identified a potential strategy for treating osteoarthritis from both a symptomatic and disease-modifying perspective by using gene therapy to inhibit the interleukin-1 pathway.